XORTX Therapeutics Inc. (XRTX)

NASDAQ

$1,92

$+0,27

(+16,27%)

Regular Market

XORTX Therapeutics Inc. (XRTX) Live Price Chart

Last updated: ⁦2026-09-18 15:41:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

XORTX Therapeutics Inc. (XRTX) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1,92, with a market capitalization of $3,23M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,58 to $7,05. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$3,23M
Open	$1,95
Day's High	$1.513,35
Day's Low	$1,58
Previous Close	$1,66
Volume	6,06M
Average Volume	106,24K
P/E Ratio	--
52-Week High	$7,05
52-Week Low	$1,58
Dividend Yield	--
Earnings Date	--

XORTX Therapeutics Inc. (XRTX) Stock Price Today

XORTX Therapeutics Inc. (XRTX) is currently trading at $1,92 as of 2026-09-18 15:39:00, up 15,42% ($0,26) from the previous close of $1,66

During today's regular trading session, XRTX has traded between $1,58 and $1.513,35, with a trading volume of 6,06M shares. The current price is near the lower end of today's range.

XORTX Therapeutics Inc. (XRTX) 7-Day Stock Price Change

Over the past seven days, XORTX Therapeutics Inc. (XRTX) moved from $2,16 to $1,92, representing a decline of 11,21% ($0,24).

The stock traded between $1,58 and $2,52 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 859,51 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

XRTX 52-Week Price Position

Position in Range: 6,2%

52W Low$1,58

52W High$7,05

XRTX is currently trading at $1,92, placing it 6,2% of the way from its 52-week low of $1,58 to its 52-week high of $7,05. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is XORTX Therapeutics Inc. (XRTX)?

XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.

XORTX Therapeutics Inc. Information

Employees	3
Exchange	NASDAQ
Company Website	https://www.xortx.com

How to Buy XORTX Therapeutics Inc. (XRTX) Stock on MEXC

Eligible investors can buy real shares of XORTX Therapeutics Inc. (XRTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for XRTX and Place Your Order

Open the RealStocks trading page and search for XRTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is XORTX Therapeutics Inc. (XRTX) stock price today?

XORTX Therapeutics Inc. (XRTX) is currently trading at $ 1,92, up 15,42% ($0,26) from the previous close of $ 1,66. Intraday prices update in real time during regular trading hours.

2.Is XRTX stock going up or down today?

As of 2026-09-18 15:39:00, XRTX is trading at $ 1,92, up 15,42% ($0,26) from its previous close of $ 1,66. The stock has traded between $ 1,58 and $ 1.513,35 during today’s regular session. Past price movements do not guarantee future results.

3.What is XRTX pre-market price?

As of 2026-09-18 15:39:00, XRTX is trading at $ 1,88 in pre-market trading, up 12,95% ($0,22) from the previous close of $ 1,66. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is XRTX after-hours price?

As of 2026-09-18 15:39:00, XRTX is trading at $ 2,07 in after-hours trading, up 24,52% ($0,41) from the regular-session close of $ 1,66. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is XRTX stock trading now?

XRTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does XRTX sit relative to its 52-week high and low?

Over the past 52 weeks, XRTX has traded between a low of $ 1,58 and a high of $ 7,05. At $ 1,92, the stock is positioned 6,2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is XORTX Therapeutics Inc. in?

XORTX Therapeutics Inc. (XRTX) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is XORTX Therapeutics Inc.'s market capitalization and where is it listed?

XORTX Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalization of $ 3,23M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is XRTX valued in terms of P/E ratio and EPS?

XRTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does XORTX Therapeutics Inc. pay a dividend?

XORTX Therapeutics Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.